Industries / Frontier science / Synthetic biology
Biosecurity
This is the work of deciding which orders for made-to-order DNA should be filled, and of writing and enforcing the rules that say so.
7
Milestones achieved, from 1975 to 2026.
2
To watch for: announced, not yet confirmed outside.
3
Open deliverables. Nobody has shipped them.
The road
AchievedWatch forOpen
Achieved
1975
The field writes its rules
The organising committee of a conference held at the Asilomar centre in California on recombinant DNA molecules, meaning DNA pieced together from more than one source, published a summary statement in the Proceedings of the National Academy of Sciences in June 1975, across four pages of its sixth issue that year. It is the earliest document in this domain, and it was written by the researchers themselves rather than by a government.
Credit
Paul Berg, David Baltimore, Sydney Brenner, Richard Roblin and Maxine Singer
2009
Synthesis firms screen together
Gene synthesis companies formed the International Gene Synthesis Consortium and agreed one protocol for checking both the sequences ordered and the customers who order them. The consortium says its members screen the DNA and the matching protein sequence of every double-stranded gene order against a curated database of regulated pathogen sequences, and that together they account for most of the world's commercial gene synthesis capacity.
Credit
International Gene Synthesis Consortium
2010
A government framework, voluntary
The US Department of Health and Human Services issued screening guidance for providers of synthetic double-stranded DNA, effective 13 October 2010, a year after publishing a draft for comment. It set out customer checks, sequence checks, follow-up steps, record keeping and whom to contact in government. Nothing in it bound a provider.
Lessonvoluntary guidance reaches only the providers who choose to follow it, which is why later versions were attached to federal funding.
Credit
US Department of Health and Human Services
2024
Screening tied to research money
The US Office of Science and Technology Policy issued a Framework for Nucleic Acid Synthesis Screening, written by a subcommittee set up under section 4.4 of the 2023 executive order on artificial intelligence. Agencies that fund life sciences research were to require, as a condition of funding, that synthetic DNA and benchtop synthesis machines be bought from providers who screen. Orders of 200 or more nucleotides were to be screened, falling to 50 from 13 October 2026.
Credit
US Office of Science and Technology Policy
2024
A screening tool, given away
The International Biosecurity and Biosafety Initiative for Science, a non-profit foundation in Geneva, published the first release of the Common Mechanism, free screening software under an MIT licence that a provider runs on its own computers so that no customer order leaves the company. The work began with a 2019 group convened by the Nuclear Threat Initiative and the World Economic Forum. By November 2026 the project was on its fifteenth release.
Credit
IBBIS
2025
A screening gap, then patches
A team from Microsoft, IBBIS, two synthesis companies and the synthesis consortium reported in Science on 2 October 2025 that screening software often failed to flag protein designs that software had redesigned. Before publishing, the authors worked with the tool makers to patch them.
Lessonscreening software goes stale as design software improves, so it has to be retested rather than installed and trusted.
Credit
Bruce Wittmann, Eric Horvitz and ten co-authors
2026
One national screening policy
On 5 November 2026 the White House issued a National Policy for Nucleic Acid Synthesis Screening. Everyone who receives US federal life sciences funding must buy synthetic DNA and benchtop machines only from suppliers the policy calls adherent: suppliers that put every order of 50 nucleotides or more through a screening tool verified by the National Institute of Standards and Technology, check who the customer is, report flagged orders, and keep the records for at least eight years. It replaces the 2024 framework.
Lessonthe 2024 framework rested on one executive order; when a later order replaced it on 5 May 2025 with a 90-day deadline to rewrite the framework, the replacement took about fifteen months, and in between no settled standard applied.
Credit
the US Office of Science and Technology Policy and the National Security Council
Watch for
The new policy's own clock
The November 2026 policy sets its own deadlines: standards and test protocols from the National Institute of Standards and Technology within 90 days, a first published list of adherent suppliers from the Department of Health and Human Services within 160 days, and funded customers buying all synthetic DNA from those suppliers within 250 days and all benchtop machines within 340 days.
Achieved whenthe standards are published, the institute is verifying screening tools, and the first list of adherent suppliers is public.
Claimed by
the White House, November 2026
Patched tools catch short pieces
Four screening tools patched after the 2025 study were tested again. Two of the four detected pieces as short as 50 nucleotides without further change, which the authors note is shorter than the 2024 US framework asked for, and upgraded versions of the other two did better than before.
Achieved whena group that took no part in patching the tools publishes the same measurement.
Claimed by
Bruce Wittmann and colleagues, July 2026
Open
01
Deadlines against what appeared
a public tracker of every dated obligation in synthesis screening policy, from the 2010 US guidance through the 2024 framework, the May 2025 executive order and the November 2026 national policy, recording for each deadline the document that set it, the date it falls, and the primary document showing what appeared and when.
The briefCredit · unclaimed02
Screening in the small print
a public table of what research funders and universities actually require of buyers, quoting the clause: the US National Institutes of Health grants policy, the National Science Foundation's award terms, Department of Defense award terms, and the purchasing rules of the fifty largest US research universities.
The briefCredit · unclaimed03
The rules, clause by clause
one open table that sets the screening rules side by side, field by field: what length of order triggers a check, who must do it, who is covered, what records are kept and for how long, and what happens to a flagged order. Cover the US documents since 2009 and the ten countries with the most providers.
The briefCredit · unclaimed
Open 01 · the brief
Deadlines against what appeared
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
a public tracker of every dated obligation in synthesis screening policy, from the 2010 US guidance through the 2024 framework, the May 2025 executive order and the November 2026 national policy, recording for each deadline the document that set it, the date it falls, and the primary document showing what appeared and when.
Why it is still open
the executive order of 5 May 2025 gave the Office of Science and Technology Policy 90 days to revise or replace the 2024 framework, and the replacement was issued on 5 November 2026, about fifteen months later. No public record follows these dates, and the superseded 2024 framework is now served from an archived White House website rather than the live one.
Built with what exists
the Federal Register's public API, govinfo, the White House site, the Internet Archive for dated snapshots, a model that reads documents and pulls out dated obligations, such as the one used for the document review in the Notes, "Seven more flagged", and any static site generator.
First step
list every date in the November 2026 policy and the May 2025 order, and record against each one what exists today.
Done looks like
every dated obligation in the five documents listed with its source, a monthly re-check, and a public list of the deadlines that passed with nothing published.
Open 02 · the brief
Screening in the small print
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
a public table of what research funders and universities actually require of buyers, quoting the clause: the US National Institutes of Health grants policy, the National Science Foundation's award terms, Department of Defense award terms, and the purchasing rules of the fifty largest US research universities.
Why it is still open
both the 2024 framework and the November 2026 policy work by making screening a condition of federal funding, which each agency is to carry into its own award terms; neither document publishes the resulting clauses, and no one has collected them.
Built with what exists
the funders' own published policy documents, universities' procurement pages, a model that extracts and quotes clauses from long documents, and a public spreadsheet.
First step
read the NIH grants policy statement and three universities' purchasing policies, and record the exact wording each uses.
Done looks like
fifty universities and six agencies, each with a dated quotation or a recorded "no clause found", every row linked to its source, and a count of how many name screening at all.
Open 03 · the brief
The rules, clause by clause
The first to publish is credited on this line, and the deliverable moves from Open to Achieved.
What to build
one open table that sets the screening rules side by side, field by field: what length of order triggers a check, who must do it, who is covered, what records are kept and for how long, and what happens to a flagged order. Cover the US documents since 2009 and the ten countries with the most providers.
Why it is still open
the Global DNA Synthesis Map, launched by IBBIS in December 2025 and expanded with a report, country pages and a tiered data portal in July 2026, gives country-level policy overviews for more than 60 countries, but as summaries rather than a clause-level comparison, and its fuller data sits behind graded access.
Built with what exists
the primary documents, a model that extracts and translates clauses, and a published CSV in which every cell quotes and links its source.
First step
fill the table for the four US documents, which are all public, and publish it with the quotations.
Done looks like
a table of twelve fields for each document and each jurisdiction, every cell quoted and linked, published with a list of the questions no document answers.